<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39355253</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>A clinical protocol for a German birth cohort study of the Maturation of Immunity Against respiratory viral Infections (MIAI).</ArticleTitle><Pagination><StartPage>1443665</StartPage><MedlinePgn>1443665</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1443665</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1443665</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Respiratory viral infections (RVIs) are a major global contributor to morbidity and mortality. The susceptibility and outcome of RVIs are strongly age-dependent and show considerable inter-population differences, pointing to genetically and/or environmentally driven developmental variability. The factors determining the age-dependency and shaping the age-related changes of human anti-RVI immunity after birth are still elusive.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We are conducting a prospective birth cohort study aiming at identifying endogenous and environmental factors associated with the susceptibility to RVIs and their impact on cellular and humoral immune responses against the influenza A virus (IAV), respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The MIAI birth cohort enrolls healthy, full-term neonates born at the University Hospital Würzburg, Germany, with follow-up at four defined time-points during the first year of life. At each study visit, clinical metadata including diet, lifestyle, sociodemographic information, and physical examinations, are collected along with extensive biomaterial sampling. Biomaterials are used to generate comprehensive, integrated multi-omics datasets including transcriptomic, epigenomic, proteomic, metabolomic and microbiomic methods.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The results are expected to capture a holistic picture of the variability of immune trajectories with a focus on cellular and humoral key players involved in the defense of RVIs and the impact of host and environmental factors thereon. Thereby, MIAI aims at providing insights that allow unraveling molecular mechanisms that can be targeted to promote the development of competent anti-RVI immunity in early life and prevent severe RVIs.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="UNASSIGNED">https://drks.de/search/de/trial/, identifier DRKS00034278.</AbstractText><CopyrightInformation>Copyright © 2024 Hartmann, Khan, Schöning, Richter, Willers, Pirr, Heckmann, Dirks, Morbach, Konrad, Fries, Winkler, Büchel, Seidenspinner, Fischer, Vollmuth, Meinhardt, Marissen, Schmolke, Haid, Pietschmann, Backes, Dölken, Löber, Keil, Heuschmann, Wöckel, Sagar, Ulas, Forslund-Startceva, Härtel and Viemann.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hartmann</LastName><ForeName>Carina R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Khan</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schöning</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willers</LastName><ForeName>Maike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirr</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heckmann</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dirks</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research, Site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morbach</LastName><ForeName>Henner</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Primary Immunodeficiencies and Autoinflammatory Diseases (CIDA), University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konrad</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fries</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Magdalene</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Büchel</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seidenspinner</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vollmuth</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meinhardt</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marissen</LastName><ForeName>Janina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmolke</LastName><ForeName>Mirco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Inflammation Research, Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haid</LastName><ForeName>Sibylle</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Experimental Virology, Centre for Experimental and Clinical Infection Research (TWINCORE), a joint venture between the Helmholtz Centre for Infection Research and The Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietschmann</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Experimental Virology, Centre for Experimental and Clinical Infection Research (TWINCORE), a joint venture between the Helmholtz Centre for Infection Research and The Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research, Partner Site Braunschweig-Hannover, Braunschweig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backes</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dölken</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Virology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Löber</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK), Partner site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keil</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heuschmann</LastName><ForeName>Peter U</ForeName><Initials>PU</Initials><AffiliationInfo><Affiliation>Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Data Science, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Trial Centre Würzburg, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wöckel</LastName><ForeName>Achim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sagar</LastName><AffiliationInfo><Affiliation>Department of Medicine II (Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases), Freiburg University Medical Center, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ulas</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Systems Medicine, German Center for Neurodegenerative Diseases Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forslund-Startceva</LastName><ForeName>Sofia K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental and Clinical Research Center, a cooperation of Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Härtel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Viemann</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, University Hospital Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection Research, University Würzburg, Würzburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089822" MajorTopicYN="N">Birth Cohort</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IAV</Keyword><Keyword MajorTopicYN="N">RSV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">anti-viral immunity</Keyword><Keyword MajorTopicYN="N">birth cohort</Keyword><Keyword MajorTopicYN="N">microbiota</Keyword><Keyword MajorTopicYN="N">multi-omics data</Keyword><Keyword MajorTopicYN="N">respiratory viral infection</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355253</ArticleId><ArticleId IdType="pmc">PMC11442434</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1443665</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, et al. . Epidemiological characteristics of four common respiratory viral infections in children. Virol J. (2021) 18:10. doi: 10.1186/s12985-020-01475-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01475-y</ArticleId><ArticleId IdType="pmc">PMC7787583</ArticleId><ArticleId IdType="pubmed">33407659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. . Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. (2010) 375:1545–55. doi: 10.1016/S0140-6736(10)60206-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60206-1</ArticleId><ArticleId IdType="pmc">PMC2864404</ArticleId><ArticleId IdType="pubmed">20399493</ArticleId></ArticleIdList></Reference><Reference><Citation>Openshaw PJ, Chiu C, Culley FJ, Johansson C. Protective and harmful immunity to RSV infection. Annu Rev Immunol. (2017) 35:501–32. doi: 10.1146/annurev-immunol-051116-052206</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-051116-052206</ArticleId><ArticleId IdType="pubmed">28226227</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi T, McAllister DA, O’Brien KL, Simoes EA, Madhi SA, Gessner BD, et al. . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. (2017) 390:946–58. doi: 10.1016/S0140-6736(17)30938-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30938-8</ArticleId><ArticleId IdType="pmc">PMC5592248</ArticleId><ArticleId IdType="pubmed">28689664</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. (2006) 368:312–22. doi: 10.1016/S0140-6736(06)69077-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)69077-6</ArticleId><ArticleId IdType="pubmed">16860701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristjansson S, Bjarnarson SP, Wennergren G, Palsdottir AH, Arnadottir T, Haraldsson A, et al. . Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. J Allergy Clin Immunol. (2005) 116:805–11. doi: 10.1016/j.jaci.2005.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2005.07.012</ArticleId><ArticleId IdType="pubmed">16210054</ArticleId></ArticleIdList></Reference><Reference><Citation>Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. (2003) 168:633–9. doi: 10.1164/rccm.200210-1148OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200210-1148OC</ArticleId><ArticleId IdType="pubmed">12773328</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravia J, You D, Shrestha B, Jaligama S, Siefker D, Lee GI, et al. . Respiratory syncytial virus disease is mediated by age-variable IL-33. PloS Pathog. (2015) 11:e1005217. doi: 10.1371/journal.ppat.1005217</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005217</ArticleId><ArticleId IdType="pmc">PMC4608776</ArticleId><ArticleId IdType="pubmed">26473724</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kleer IM, Kool M, de Bruijn MJW, Willart M, van Moorleghem J, Schuijs MJ, et al. . Perinatal activation of the interleukin-33 pathway promotes type 2 immunity in the developing lung. Immunity. (2016) 45:1285–98. doi: 10.1016/j.immuni.2016.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.10.031</ArticleId><ArticleId IdType="pubmed">27939673</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2017 Influenza Collaborators . Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. (2019) 7:69–89. doi: 10.1016/S2213-2600(18)30496-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30496-X</ArticleId><ArticleId IdType="pmc">PMC6302221</ArticleId><ArticleId IdType="pubmed">30553848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulas T, Pirr S, Fehlhaber B, Bickes MS, Loof TG, Vogl T, et al. . S100-alarmin-induced innate immune programming protects newborn infants from sepsis. Nat Immunol. (2017) 18:622–32. doi: 10.1038/ni.3745</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3745</ArticleId><ArticleId IdType="pubmed">28459433</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook B, Harbeson D, Ben-Othman R, Viemann D, Kollmann TR. Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen. Semin Immunopathol. (2017) 39:615–25. doi: 10.1007/s00281-017-0651-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0651-z</ArticleId><ArticleId IdType="pubmed">29098373</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneke P, Kierdorf K, Hall LJ, Sperandio M, Hornef M. Perinatal development of innate immune topology. Elife. (2021) 10:e67793. doi: 10.7554/eLife.67793</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.67793</ArticleId><ArticleId IdType="pmc">PMC8149122</ArticleId><ArticleId IdType="pubmed">34032570</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC - Centers for Disease Control and Prevention . Influenza vaccination coverage for persons 6 months and older(2021). Available online at: https://www.cdc.gov/flu/fluvaxview/interactive-general-population.htm. (Accessed August 8, 2024).</Citation></Reference><Reference><Citation>Hoang U, Delanerolle G, Fan X, Aspden C, Byford R, Ashraf M, et al. . A profile of influenza vaccine coverage for 2019-2020: database study of the english primary care sentinel cohort. JMIR Public Health Surveill. (2024) 10:e39297. doi: 10.2196/39297</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/39297</ArticleId><ArticleId IdType="pmc">PMC11161707</ArticleId><ArticleId IdType="pubmed">38787605</ArticleId></ArticleIdList></Reference><Reference><Citation>Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. JAMA Pediatr. (2020) 174:882–9. doi: 10.1001/jamapediatrics.2020.1467</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1467</ArticleId><ArticleId IdType="pubmed">32320004</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Gu J, Chen Q, Deng N, Li J, Huang L, et al. . Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series. PloS Med. (2020) 17:e1003130. doi: 10.1371/journal.pmed.1003130</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003130</ArticleId><ArticleId IdType="pmc">PMC7297312</ArticleId><ArticleId IdType="pubmed">32544155</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou J, Thomas PG, Randolph AG. Immunology of SARS-CoV-2 infection in children. Nat Immunol. (2022) 23:177–85. doi: 10.1038/s41590-021-01123-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01123-9</ArticleId><ArticleId IdType="pmc">PMC8981222</ArticleId><ArticleId IdType="pubmed">35105983</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske J, Röhmel J, Lukassen S, Stricker S, Magalhães VG, Liebig J, et al. . Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat Biotechnol. (2021) 40:319–24. doi: 10.1038/s41587-021-01037-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01037-9</ArticleId><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Worlock KB, Huang N, Lindeboom RG, Butler CR, Kumasaka N, et al. . Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature. (2022) 602:321–7. doi: 10.1038/s41586-021-04345-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04345-x</ArticleId><ArticleId IdType="pmc">PMC8828466</ArticleId><ArticleId IdType="pubmed">34937051</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodall MN, Cujba A-M, Worlock KB, Case K-M, Masonou T, Yoshida M, et al. . Age-specific nasal epithelial responses to SARS-CoV-2 infection. Nat Microbiol. (2024) 9:1293–311. doi: 10.1038/s41564-024-01658-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-024-01658-1</ArticleId><ArticleId IdType="pmc">PMC11087271</ArticleId><ArticleId IdType="pubmed">38622380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollmann TR, Kampmann B, Mazmanian SK, Marchant A, Levy O. Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny. Immunity. (2017) 46:350–63. doi: 10.1016/j.immuni.2017.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.03.009</ArticleId><ArticleId IdType="pubmed">28329702</ArticleId></ArticleIdList></Reference><Reference><Citation>Torow N, Hand TW, Hornef MW. Programmed and environmental determinants driving neonatal mucosal immune development. Immunity. (2023) 56:485–99. doi: 10.1016/j.immuni.2023.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2023.02.013</ArticleId><ArticleId IdType="pmc">PMC10079302</ArticleId><ArticleId IdType="pubmed">36921575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhivaki D, Lo-Man R. Unique aspects of the perinatal immune system. Nat Rev Immunol. (2017) 17:495–507. doi: 10.1038/nri.2017.54</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.54</ArticleId><ArticleId IdType="pubmed">28627520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. (2016) 375:2369–79. doi: 10.1056/NEJMra1600266</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Simone SK, Rudloff I, Nold-Petry CA, Forster SC, Nold MF. Understanding respiratory microbiome-immune system interactions in health and disease. Sci Transl Med. (2023) 15:eabq5126. doi: 10.1126/scitranslmed.abq5126</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq5126</ArticleId><ArticleId IdType="pubmed">36630485</ArticleId></ArticleIdList></Reference><Reference><Citation>Biesbroek G, Tsivtsivadze E, Sanders EA, Montijn R, Veenhoven RH, Keijser BJ, et al. . Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med. (2014) 190:1283–92. doi: 10.1164/rccm.201407-1240OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201407-1240OC</ArticleId><ArticleId IdType="pubmed">25329446</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch AATM, de Steenhuijsen Piters WAA, van Houten MA, Chu MLJN, Biesbroek G, Kool J, et al. . Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. A prospective cohort study. Am J Respir Crit Care Med. (2017) 196:1582–90. doi: 10.1164/rccm.201703-0554OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201703-0554OC</ArticleId><ArticleId IdType="pubmed">28665684</ArticleId></ArticleIdList></Reference><Reference><Citation>de Steenhuijsen Piters WAA, Binkowska J, Bogaert D. Early life microbiota and respiratory tract infections. Cell Host Microbe. (2020) 28:223–32. doi: 10.1016/j.chom.2020.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.07.004</ArticleId><ArticleId IdType="pubmed">32791114</ArticleId></ArticleIdList></Reference><Reference><Citation>de Steenhuijsen Piters WAA, Watson RL, de Koff EM, Hasrat R, Arp K, Chu MLJN, et al. . Early-life viral infections are associated with disadvantageous immune and microbiota profiles and recurrent respiratory infections. Nat Microbiol. (2022) 7:224–37. doi: 10.1038/s41564-021-01043-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-01043-2</ArticleId><ArticleId IdType="pubmed">35058634</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, et al. . The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. (2015) 17:704–15. doi: 10.1016/j.chom.2015.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.03.008</ArticleId><ArticleId IdType="pmc">PMC4433433</ArticleId><ArticleId IdType="pubmed">25865368</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes KH, Fachi JL, de Paula R, Da Silva EF, Pral LP, Dos Santos AÁ, et al. . Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. (2019) 10:3273. doi: 10.1038/s41467-019-11152-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11152-6</ArticleId><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo VL, Lieber CM, Kang H-J, Sakamoto K, Kuczma M, Plemper RK, et al. . Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection. Cell Host Microbe. (2024) 32:335–348.e8. doi: 10.1016/j.chom.2024.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2024.01.002</ArticleId><ArticleId IdType="pmc">PMC10942762</ArticleId><ArticleId IdType="pubmed">38295788</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JN, Siefker D, Vu L, You D, DeVincenzo J, Pierre JF, et al. . Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity. BMC Microbiol. (2020) 20:140. doi: 10.1186/s12866-020-01816-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-020-01816-5</ArticleId><ArticleId IdType="pmc">PMC7268675</ArticleId><ArticleId IdType="pubmed">32487019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Dong BR, Hao Q. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. (2022) 8:CD006895. doi: 10.1002/14651858.CD006895.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006895.pub4</ArticleId><ArticleId IdType="pmc">PMC9400717</ArticleId><ArticleId IdType="pubmed">36001877</ArticleId></ArticleIdList></Reference><Reference><Citation>Du T, Lei A, Zhang N, Zhu C. The beneficial role of probiotic lactobacillus in respiratory diseases. Front Immunol. (2022) 13:908010. doi: 10.3389/fimmu.2022.908010</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.908010</ArticleId><ArticleId IdType="pmc">PMC9194447</ArticleId><ArticleId IdType="pubmed">35711436</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi HY, Zhu X, Li WL, Mak JW, Wong SH, Zhu ST, et al. . Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies. Eur J Nutr. (2021) 60:4151–74. doi: 10.1007/s00394-021-02519-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-021-02519-x</ArticleId><ArticleId IdType="pmc">PMC8044287</ArticleId><ArticleId IdType="pubmed">33852069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt H, Burke C, Haghi M. Manipulation of the upper respiratory microbiota to reduce incidence and severity of upper respiratory viral infections: A literature review. Front Microbiol. (2021) 12:713703. doi: 10.3389/fmicb.2021.713703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.713703</ArticleId><ArticleId IdType="pmc">PMC8432964</ArticleId><ArticleId IdType="pubmed">34512591</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper A, Vijayakumar V, Ouwehand AC, Haar JT, Obis D, Espadaler J, et al. . Viral infections, the microbiome, and probiotics. Front Cell Infect Microbiol. (2020) 10:596166. doi: 10.3389/fcimb.2020.596166</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.596166</ArticleId><ArticleId IdType="pmc">PMC7907522</ArticleId><ArticleId IdType="pubmed">33643929</ArticleId></ArticleIdList></Reference><Reference><Citation>Suez J, Zmora N, Segal E, Elinav E. The pros, cons, and many unknowns of probiotics. Nat Med. (2019) 25:716–29. doi: 10.1038/s41591-019-0439-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0439-x</ArticleId><ArticleId IdType="pubmed">31061539</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen KM, Catalano PM, Yaktine AL. New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol. (2009) 21:521–6. doi: 10.1097/GCO.0b013e328332d24e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/GCO.0b013e328332d24e</ArticleId><ArticleId IdType="pmc">PMC2847829</ArticleId><ArticleId IdType="pubmed">19809317</ArticleId></ArticleIdList></Reference><Reference><Citation>Martens A, Amann G, Schmidt K, Gaupmann R, Böhm B, Dehlink E, et al. . An optimized, robust and reproducible protocol to generate well-differentiated primary nasal epithelial models from extremely premature infants. Sci Rep. (2019) 9:20069. doi: 10.1038/s41598-019-56737-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56737-9</ArticleId><ArticleId IdType="pmc">PMC6934534</ArticleId><ArticleId IdType="pubmed">31882915</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsdottir HR, Dijkman R. Characterization of human coronaviruses on well-differentiated human airway epithelial cell cultures. Methods Mol Biol. (2015) 1282:73–87. doi: 10.1007/978-1-4939-2438-7_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2438-7_8</ArticleId><ArticleId IdType="pmc">PMC7124022</ArticleId><ArticleId IdType="pubmed">25720473</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber A, Viemann D, Schöning J, Schloer S, Mecate Zambrano A, Brunotte L, et al. . The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Cell Mol Life Sci. (2022) 79:65. doi: 10.1007/s00018-021-04085-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04085-1</ArticleId><ArticleId IdType="pmc">PMC8747446</ArticleId><ArticleId IdType="pubmed">35013790</ArticleId></ArticleIdList></Reference><Reference><Citation>Sake SM, Zhang X, Rajak MK, Urbanek-Quaing M, Carpentier A, Gunesch AP, et al. . Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nat Commun. (2024) 15:1173. doi: 10.1038/s41467-024-45241-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-45241-y</ArticleId><ArticleId IdType="pmc">PMC10853176</ArticleId><ArticleId IdType="pubmed">38332002</ArticleId></ArticleIdList></Reference><Reference><Citation>de Domenico E, Bonaguro L, Schulte-Schrepping J, Becker M, Händler K, Schultze JL. Optimized workflow for single-cell transcriptomics on infectious diseases including COVID-19. STAR Protoc. (2020) 1:100233. doi: 10.1016/j.xpro.2020.100233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2020.100233</ArticleId><ArticleId IdType="pmc">PMC7757730</ArticleId><ArticleId IdType="pubmed">33377120</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M, Brito F, Benaoudia S, Royston L, Cagno V, Fernandes-Rocha M, et al. . Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. J Allergy Clin Immunol. (2018) 141:2074–84. doi: 10.1016/j.jaci.2017.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.07.018</ArticleId><ArticleId IdType="pmc">PMC7112338</ArticleId><ArticleId IdType="pubmed">28797733</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson E, Kaler L, Agostino EL, Song D, Duncan GA, Scull MA. Leveraging 3D model systems to understand viral interactions with the respiratory mucosa. Viruses. (2020) 12:1425. doi: 10.3390/v12121425</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12121425</ArticleId><ArticleId IdType="pmc">PMC7763686</ArticleId><ArticleId IdType="pubmed">33322395</ArticleId></ArticleIdList></Reference><Reference><Citation>Viemann D. S100-alarmins are essential pilots of postnatal innate immune adaptation. Front Immunol. (2020) 11:688. doi: 10.3389/fimmu.2020.00688</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00688</ArticleId><ArticleId IdType="pmc">PMC7203218</ArticleId><ArticleId IdType="pubmed">32425933</ArticleId></ArticleIdList></Reference><Reference><Citation>Willers M, Ulas T, Völlger L, Vogl T, Heinemann AS, Pirr S, et al. . S100A8 and S100A9 are important for postnatal development of gut microbiota and immune system in mice and infants. Gastroenterology. (2020) 159:2130–2145.e5. doi: 10.1053/j.gastro.2020.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.08.019</ArticleId><ArticleId IdType="pubmed">32805279</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirks J, Andres O, Paul L, Manukjan G, Schulze H, Morbach H. IgD shapes the pre-immune naïve B cell compartment in humans. Front Immunol. (2023) 14:1096019. doi: 10.3389/fimmu.2023.1096019</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1096019</ArticleId><ArticleId IdType="pmc">PMC9908586</ArticleId><ArticleId IdType="pubmed">36776874</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirks J, Viemann D, Beyersdorf N, Härtel C, Morbach H. Insights into B-cell ontogeny inferred from human immunology. Eur J Immunol. (2023) 53:e2250116. doi: 10.1002/eji.202250116</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202250116</ArticleId><ArticleId IdType="pubmed">36905220</ArticleId></ArticleIdList></Reference><Reference><Citation>León-Lara X, Fichtner AS, Willers M, Yang T, Schaper K, Riemann L, et al. . γδ T cell profiling in a cohort of preterm infants reveals elevated frequencies of CD83+ γδ T cells in sepsis. J Exp Med. (2024) 221:e20231987. doi: 10.1084/jem.20231987</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20231987</ArticleId><ArticleId IdType="pmc">PMC11098939</ArticleId><ArticleId IdType="pubmed">38753245</ArticleId></ArticleIdList></Reference><Reference><Citation>Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol. (2010) 162:271–9. doi: 10.1111/j.1365-2249.2010.04206.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2010.04206.x</ArticleId><ArticleId IdType="pmc">PMC2996594</ArticleId><ArticleId IdType="pubmed">20854328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens S, Fichtner AS, Willers M, Torkornoo D, Pirr S, Schöning J, et al. . Microbial exposure drives polyclonal expansion of innate γδ T cells immediately after birth. Proc Natl Acad Sci U.S.A. (2020) 117:18649–60. doi: 10.1073/pnas.1922588117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1922588117</ArticleId><ArticleId IdType="pmc">PMC7414158</ArticleId><ArticleId IdType="pubmed">32690687</ArticleId></ArticleIdList></Reference><Reference><Citation>Austermann J, Friesenhagen J, Fassl SK, Petersen B, Ortkras T, Burgmann J, et al. . Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions. Cell Rep. (2014) 9:2112–23. doi: 10.1016/j.celrep.2014.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.11.020</ArticleId><ArticleId IdType="pubmed">25497086</ArticleId></ArticleIdList></Reference><Reference><Citation>Büttner M, Hempel F, Ryborz T, Theis FJ, Schultze JL. Pytometry: Flow and mass cytometry analytics in Python. bioRxiv preprint. (2022). doi: 10.1101/2022.10.10.511546</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.10.10.511546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroeger C, Müller S, Leidner J, Kröber T, Warnat-Herresthal S, Spintge JB, et al. . Unveiling the Power of High-Dimensional Cytometry Data with cyCONDOR. bioRxiv preprint (2024). doi: 10.1101/2024.02.29.582727</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.29.582727</ArticleId></ArticleIdList></Reference><Reference><Citation>Holsten L, Dahm K, Oestreich M, Becker M, Ulas T. hCoCena: A toolbox for network-based co-expression analysis and horizontal integration of transcriptomic datasets. STAR Protoc. (2024) 5:102922. doi: 10.1016/j.xpro.2024.102922</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2024.102922</ArticleId><ArticleId IdType="pmc">PMC10918327</ArticleId><ArticleId IdType="pubmed">38427570</ArticleId></ArticleIdList></Reference><Reference><Citation>Oestreich M, Holsten L, Agrawal S, Dahm K, Koch P, Jin H, et al. . hCoCena: horizontal integration and analysis of transcriptomics datasets. Bioinformatics. (2022) 38:4727–34. doi: 10.1093/bioinformatics/btac589</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btac589</ArticleId><ArticleId IdType="pmc">PMC9563699</ArticleId><ArticleId IdType="pubmed">36018233</ArticleId></ArticleIdList></Reference><Reference><Citation>Forslund SK, Chakaroun R, Zimmermann-Kogadeeva M, Markó L, Aron-Wisnewsky J, Nielsen T, et al. . Combinatorial, additive and dose-dependent drug-microbiome associations. Nature. (2021) 600:500–5. doi: 10.1038/s41586-021-04177-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04177-9</ArticleId><ArticleId IdType="pubmed">34880489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C-Y, Löber U, Forslund SK. LongDat: an R package for covariate-sensitive longitudinal analysis of high-dimensional data. Bioinform Adv. (2023) 3:vbad063. doi: 10.1093/bioadv/vbad063</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioadv/vbad063</ArticleId><ArticleId IdType="pmc">PMC10284677</ArticleId><ArticleId IdType="pubmed">37359720</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir A, Erez-Granat O, Braun T, Sosnovski K, Hadar R, BenShoshan M, et al. . Gut microbiome development in early childhood is affected by day care attendance. NPJ Biofilms Microbiomes. (2022) 8:2. doi: 10.1038/s41522-021-00265-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00265-w</ArticleId><ArticleId IdType="pmc">PMC8752763</ArticleId><ArticleId IdType="pubmed">35017536</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart CJ, Ajami NJ, O’Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. . Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. (2018) 562:583–8. doi: 10.1038/s41586-018-0617-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0617-x</ArticleId><ArticleId IdType="pmc">PMC6415775</ArticleId><ArticleId IdType="pubmed">30356187</ArticleId></ArticleIdList></Reference><Reference><Citation>Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. (2023) 613:130–7. doi: 10.1038/s41586-022-05522-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05522-2</ArticleId><ArticleId IdType="pmc">PMC9812776</ArticleId><ArticleId IdType="pubmed">36517599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. . The burden of respiratory syncytial virus infection in young children. N Engl J Med. (2009) 360:588–98. doi: 10.1056/NEJMoa0804877</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0804877</ArticleId><ArticleId IdType="pmc">PMC4829966</ArticleId><ArticleId IdType="pubmed">19196675</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. (2022) 399:2047–64. doi: 10.1016/S0140-6736(22)00478-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00478-0</ArticleId><ArticleId IdType="pmc">PMC7613574</ArticleId><ArticleId IdType="pubmed">35598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Cobat A, Casanova J-L. Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature. (2022) 603:587–98. doi: 10.1038/s41586-022-04447-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbester JL, Humphreys IR. Genetic influences on viral-induced cytokine responses in the lung. Mucosal Immunol. (2021) 14:14–25. doi: 10.1038/s41385-020-00355-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00355-6</ArticleId><ArticleId IdType="pmc">PMC7658619</ArticleId><ArticleId IdType="pubmed">33184476</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandstetter S, Toncheva AA, Niggel J, Wolff C, Gran S, Seelbach-Göbel B, et al. . KUNO-Kids birth cohort study: rationale, design, and cohort description. Mol Cell Pediatr. (2019) 6:1. doi: 10.1186/s40348-018-0088-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40348-018-0088-z</ArticleId><ArticleId IdType="pmc">PMC6326917</ArticleId><ArticleId IdType="pubmed">30627823</ArticleId></ArticleIdList></Reference><Reference><Citation>Pangratz-Fuehrer S, Genzel-Boroviczény O, Bodensohn WE, Eisenburger R, Scharpenack J, Geyer PE, et al. . Cohort profile: the MUNICH Preterm and Term Clinical study (MUNICH-PreTCl), a neonatal birth cohort with focus on prenatal and postnatal determinants of infant and childhood morbidity. BMJ Open. (2021) 11:e050652. doi: 10.1136/bmjopen-2021-050652</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-050652</ArticleId><ArticleId IdType="pmc">PMC8231068</ArticleId><ArticleId IdType="pubmed">34168035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransson E, Gudnadottir U, Hugerth LW, Itzel EW, Hamsten M, Boulund F, et al. . Cohort profile: the Swedish Maternal Microbiome project (SweMaMi) - assessing the dynamic associations between the microbiome and maternal and neonatal adverse events. BMJ Open. (2022) 12:e065825. doi: 10.1136/bmjopen-2022-065825</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065825</ArticleId><ArticleId IdType="pmc">PMC9615996</ArticleId><ArticleId IdType="pubmed">36288838</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfini C, Clavenna A, Cartabia M, Campi R, Bonati M. National, longitudinal NASCITA birth cohort study to investigate the health of Italian children and potential influencing factors. BMJ Open. (2022) 12:e063394. doi: 10.1136/bmjopen-2022-063394</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063394</ArticleId><ArticleId IdType="pmc">PMC9668025</ArticleId><ArticleId IdType="pubmed">36379649</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, Gálvez NM, Canedo-Marroquín G, Pizarro-Ortega MS, Andrade-Parra C, Gómez-Santander F, et al. . Contribution of cytokines to tissue damage during human respiratory syncytial virus infection. Front Immunol. (2019) 10:452. doi: 10.3389/fimmu.2019.00452</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00452</ArticleId><ArticleId IdType="pmc">PMC6431622</ArticleId><ArticleId IdType="pubmed">30936869</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, et al. . Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza. Nat Immunol. (2018) 19:625–35. doi: 10.1038/s41590-018-0111-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0111-5</ArticleId><ArticleId IdType="pmc">PMC5985949</ArticleId><ArticleId IdType="pubmed">29777224</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, et al. . In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. (2009) 460:1021–5. doi: 10.1038/nature08260</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08260</ArticleId><ArticleId IdType="pmc">PMC2748827</ArticleId><ArticleId IdType="pubmed">19672242</ArticleId></ArticleIdList></Reference><Reference><Citation>To KK, Hung IF, Li IW, Lee K-L, Koo C-K, Yan W-W, et al. . Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. (2010) 50:850–9. doi: 10.1086/650581</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/650581</ArticleId><ArticleId IdType="pmc">PMC7107930</ArticleId><ArticleId IdType="pubmed">20136415</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. (2014) 14:315–28. doi: 10.1038/nri3665</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3665</ArticleId><ArticleId IdType="pmc">PMC4104278</ArticleId><ArticleId IdType="pubmed">24762827</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. (2020) 20:355–62. doi: 10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neill MB, Quach H, Pothlichet J, Aquino Y, Bisiaux A, Zidane N, et al. . Single-cell and bulk RNA-sequencing reveal differences in monocyte susceptibility to influenza A virus infection between Africans and Europeans. Front Immunol. (2021) 12:768189. doi: 10.3389/fimmu.2021.768189</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.768189</ArticleId><ArticleId IdType="pmc">PMC8667309</ArticleId><ArticleId IdType="pubmed">34912340</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyman M, van Houten MA, van Baarle D, Bosch AATM, Man WH, Chu MLJN, et al. . Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life. Nat Commun. (2019) 10:4997. doi: 10.1038/s41467-019-13014-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13014-7</ArticleId><ArticleId IdType="pmc">PMC6825150</ArticleId><ArticleId IdType="pubmed">31676793</ArticleId></ArticleIdList></Reference><Reference><Citation>Alba C, Aparicio M, González-Martínez F, González-Sánchez MI, Pérez-Moreno J, Del Toledo Castillo B, et al. . Nasal and fecal microbiota and immunoprofiling of infants with and without RSV bronchiolitis. Front Microbiol. (2021) 12:667832. doi: 10.3389/fmicb.2021.667832</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.667832</ArticleId><ArticleId IdType="pmc">PMC8203809</ArticleId><ArticleId IdType="pubmed">34140944</ArticleId></ArticleIdList></Reference><Reference><Citation>Følsgaard NV, Schjørring S, Chawes BL, Rasmussen MA, Krogfelt KA, Brix S, et al. . Pathogenic bacteria colonizing the airways in asymptomatic neonates stimulates topical inflammatory mediator release. Am J Respir Crit Care Med. (2013) 187:589–95. doi: 10.1164/rccm.201207-1297OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201207-1297OC</ArticleId><ArticleId IdType="pubmed">23370914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>